Correction to: The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer (Cancer and Metastasis Reviews, (2022), 41, 2, (347-366), 10.1007/s10555-022-10039-1)

Philip Bredin, Jarushka Naidoo

Research output: Contribution to journalComment/debatepeer-review

Abstract

The article The gut microbiome, immune check point inhibition and immune‑related adverse events in non‑small cell lung cancer, written by Philip Bredin and Jarushka Naidoo, was originally published online first without Open Access. After publication in volume 41, issue 2, page 347–366, the author decided to opt for Open Choice and to make the article an Open Access publication.

Original languageEnglish (US)
Pages (from-to)865
Number of pages1
JournalCancer and Metastasis Reviews
Volume43
Issue number2
DOIs
StatePublished - Jun 2024
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer (Cancer and Metastasis Reviews, (2022), 41, 2, (347-366), 10.1007/s10555-022-10039-1)'. Together they form a unique fingerprint.

Cite this